Thus, SETDB2 expression and function detected in our study were similar to those of SETDB1 and SUV39H1 in cancers [5, 6], suggesting that SETDB2 may have oncogenic functions and overexpression of SETDB2 play roles in gastric cancer progression. This evidence concerns the gene SETDB1 and gastric cancer.